StonvexLoading…
StonvexStonvexStonvexCore line items from BLDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.19B | $16.40B | $17.10B | $22.73B |
Operating Income | $786.28M | $1.60B | $2.18B | $3.77B |
Net Income | $435.20M | $1.08B | $1.54B | $2.75B |
EPS (Diluted) | $3.89 | $9.06 | $11.94 | $16.82 |
Total Assets | $11.24B | $10.58B | $10.50B | $10.60B |
Total Liabilities | $6.89B | $6.29B | $5.77B | $5.63B |
Cash & Equivalents | $181.75M | $153.62M | $66.16M | $80.44M |
Free Cash Flow OCF − CapEx | $853.28M | $1.49B | $1.83B | $3.26B |
Shares Outstanding | 110.58M | 113.58M | 121.86M | 138.86M |